Myocardial Fibrosis as an Early Manifestation of Hypertrophic Cardiomyopathy
Author(s) -
Carolyn Y. Ho,
Begoña López,
Otávio R. CoelhoFilho,
Neal K. Lakdawala,
Allison L. Cirino,
Petr Jarolı́m,
Raymond Y. Kwong,
Arantxa González,
Steven D. Colan,
Jonathan G. Seidman,
Javier Dı́ez,
Christine E. Seidman
Publication year - 2010
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1002659
Subject(s) - hypertrophic cardiomyopathy , medicine , myocardial fibrosis , muscle hypertrophy , cardiology , fibrosis , left ventricular hypertrophy , cardiomyopathy , heart failure , sarcomere , endocrinology , myocyte , blood pressure
Myocardial fibrosis is a hallmark of hypertrophic cardiomyopathy and a proposed substrate for arrhythmias and heart failure. In animal models, profibrotic genetic pathways are activated early, before hypertrophic remodeling. Data showing early profibrotic responses to sarcomere-gene mutations in patients with hypertrophic cardiomyopathy are lacking.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom